Received May 12, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (QUADRACEL) | SANOFI PASTEUR | UNK | — | — |
patient was uncooperative and did not receive the full dose with no reported adverse event; Initial information received on 29-Apr-2026 regarding an unsolicited valid non-serious case received from a healthcare professional (health care professional other). This case involves a patient of unknown age and unknown gender who was uncooperative and did not receive the full dose with no reported adverse event after receiving Diphtheria-15/Tetanus/5 Hybrid Ac Pertussis/Ipv (Mrc5) Vaccine (Vquadracel). The patient's past medical history, medical treatment(s), vaccination(s), and family history were not provided. On an unknown date, the patient received a 1X once dose of Diphtheria-15/Tetanus/5 Hybrid Ac Pertussis/Ipv (Mrc5) Vaccine suspension for injection (batch/lot number: unknown; expiry date: 2027-08-31) (strength: Standard) via unknown route in an unknown administration site for immunization (Immunisation) with no adverse event (Incorrect dose administered) (Latency: same day). Action taken: Not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medication error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Comments: NONE